Minerva Neurosciences | Resultado Líquido

Net Income Alterar Data
Acadia Pharmaceuticals USD 45.8M 110.97M 2023-12
Adma Biologics USD -17645000 20.21M 2023-12
ALKERMES USD 47.76M 189.31M 2023-09
AstraZeneca USD 1.37B 444M 2023-09
Bristol-Myers Squibb USD 1.76B 166M 2023-12
Cipla INR 11.31B 1.35B 2023-09
Clal Biotechnology ILS -6166000 15.56M 2022-12
Compugen USD -9852000 576K 2023-09
CSL USD 570.8M 1.05B 2023-06
Dynavax Technologies USD 219K 14.07M 2023-12
Eli Lilly USD 2.19B 2.25B 2023-12
GlaxoSmithKline GBP 1.46B 160M 2023-09
Grifols EUR 59.54M 7.5M 2023-09
Halozyme Therapeutics USD 85.39M 3.55M 2023-12
Ionis Pharmaceuticals USD -9263000 138.15M 2023-12
Merck USD -1226000000 5.97B 2023-12
Neurocrine Biosciences USD 83.1M 12.4M 2023-09
Pfizer USD -3368000000 986M 2023-12
Roche Holding CHF 7.14B 3.25B 2023-06
Takeda JPY -48030000000 137.43B 2023-09



Minerva Neurosciences Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.